Jeffery W. Kelly

Awards

1. 2022

   Breakthrough Prize — Life Sciences

   Biology

   for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.

2. 2023

   Wolf Prize — Chemistry

   Chemistry

   for developing a clinical strategy to ameliorate pathological protein aggregation.

3. 2026

   Canada Gairdner International Award

   Biology

   For discovering the anti-aggregation drug, tafamidis, the first effective treatment for a human amyloid disease, specifically transthyretin amyloidosis, providing the first pharmacological evidence that protein aggregation drives neurodegeneration.